MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059974 A) filed by Noida Institute Of Engineering And Technology Pharmacy Institute on May 12, 2026, for A Targeted Drug Delivery System For Autoimmune Disorders.
Inventors include Ashish Joshi; and Neha Sharma.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The invention relates to a targeted drug delivery system for autoimmune disorders comprising a biodegradable carrier body, therapeutic payload compartment, stimulus responsive release matrix, immune compatible surface layer, and dual targeting ligand sets. The system localizes a therapeutic agent toward inflamed immune tissue by recognizing disease associated vascular and immune markers. The release matrix protects the payload during transit and enables controlled liberation under lesion related biochemical conditions. The invention improves local pharmacological availability, reduces unnecessary systemic exposure, and supports adaptable treatment of autoimmune inflammatory conditions.
Disclaimer: Curated by HT Syndication.
